V(D)J recombination deficiencies

Advances in Experimental Medicine and Biology

Volumn 650, Issue , 2009, Pages 46-58

  De Villartay, Jean Pierre ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMIS; B LYMPHOCYTE RECEPTOR; CERNUNNOS; CYCLIN B; MEMBRANE PROTEIN; NONHOMOLOGOUS END JOINING PROTEIN; NUCLEIC ACID BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE IV; RAG1 PROTEIN; RAG2 PROTEIN; RECOMBINASE; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; HOMEODOMAIN PROTEIN; NHEJ1 PROTEIN, HUMAN; RAG 1 PROTEIN; RAG-1 PROTEIN; RAG2 PROTEIN, MOUSE;

ARTICLE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; DNA REPAIR; ENZYME SPECIFICITY; GENE LOCUS; GENE MUTATION; GENETIC RECOMBINATION; HUMAN; IMMUNE SYSTEM; IMMUNOPATHOGENESIS; IONIZING RADIATION; MEMORY CELL; MOLECULAR DYNAMICS; NONHUMAN; OMENN SYNDROME; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; SEVERE COMBINED IMMUNODEFICIENCY; T LYMPHOCYTE; VDJ EXON; ANIMAL; DNA DAMAGE; GENE REARRANGEMENT; GENETICS; IMMUNE DEFICIENCY; IMMUNOLOGY; METABOLISM; REVIEW; SYNDROME;

MUS;

ANIMALS; DNA DAMAGE; DNA REPAIR; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; GENE REARRANGEMENT, B-LYMPHOCYTE; GENE REARRANGEMENT, T-LYMPHOCYTE; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; RECOMBINATION, GENETIC; SEVERE COMBINED IMMUNODEFICIENCY; SYNDROME; VDJ RECOMBINASES;

EID: 70349574621     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-0296-2_4     Document Type: Article

References (107)

1. Tonegawa S, Somatic generation of antibody diversity. Nature 1983;302(5909):575-81.
2. Schatz DG, Oettinger MA. Baltimore D. The V(D)J recombination activating gene. RAG-I. Cell 1989; 59(6) :1035-48. (Pubitemid 20024615)
3. Oettinger MA, Schatz DG. Gorka C et al. RAG-I and RAG-2. adjacent genes that synergistically activate V(D)J recombination. Science 1990; 248(4962):1517-23 .
4. Dudley DD, Chaudhuri J, Bassing CH et al. Mechanism and Control of V(D)J Recombination versus Class Switch Recombination: Similarities and Differences. Adv Immunol 2005; 8643-112.
5. Fischer A. Human primary immunodeficiency diseases: a perspective. Nat Immunol 2004; 5(1):23-30.
6. Villa A, Sobacchi C. Notarangelo LD et al. V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinicaI presentations. Blood 2001; 97(1):81-8. (Pubitemid 32061245)
7. Shinkai Y, Rathbun G. LamKP et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 1992; 68(5) :855-67.
8. Mombaerts P, Iacomini J.Johnson RS et al. RAG-I-deficicnt mice have no mature B- and T-lymphocytes. Cell 1992; 68(5) :869-77.
9. Schwarz K, Hansen-Hagge TE. Knobloch C et al. Severe combined immunodeficiency (SCI D) in man: Bvcell-negative (B-) SCID patients exhibit an irregular recombination pattern at the JH locus. J Exp Med 1991; 174(5) :1039-48.
10. Abe T, Tsuge 1. Kamachi Y et al. Evidence for defects in V(D)J rearrangements in patients with severe combined immunodeficiency.J Immuno11994; 152(11) :5504-13. (Pubitemid 24153000)
11. Schwarz K, Gauss GH. Ludwig L et al. RAG mutations in human B-cell-negativeSCID. Science 1996; 274(5284):97-9.
12. Sobacchi C, Marrella V, Rucci F et al. RAG-dependent primary immunodeficiencies. Hum Murat 2006; 27(12) :1174-84. (Pubitemid 44749719)
13. Omenn GS, Familial Reticuloendorhellosis with Eosinophilia. N Engl J Med 1965; 273:427-32.
14. de Saint-Basile G. Le Deist F. de Villartay J P, et al. Restricted heterogeneity of T-lymphocytes in combined immunodeficiency with hypereosinophilia (Omena's syndrome). J Clin Invest 1991; 87(4) :1352-9.
15. Villa A, Santagata S. Bozzi F et al, Partial V(D)J recombination activity leads to Omenn syndrome. Cell 1998; 93(5) :885-96. (Pubitemid 28257593)
16. Corneo B, Moshous D. Gungor T et al. Identical mutations in RAG1 or RAG2 genes leading to defective V(D)J recornbinase activity can cause either T-B-severe combined immune deficiency or Omenn syndrome. Blood 2001; 97(9) :2772-6.
17. Ege M, Ma Y. Manfras B et al. Omenn syndrome due to ARTEMIS mutations. Blood 2005; 105(11):4179-86. (Pubitemid 40720760)
18. Giliani S, Bonfim C. de Saint Basile G et al. Omenn syndrome in an infant with IL7RA gene mutation. J Pediatr 2006; 148(2):272-4. (Pubitemid 43286773)
19. Roifman CM, Gu Y. Cohen A. Mutations in the RNA component of RNase mitochondrial RNA processing might cause Omenn syndrome. J Allergy Clin Immunol 2006; 117(4) :897-903.
20. Markert ML, Alexieff MJ. Li J et al. Complete DiGeorge syndrome: development of rash. lymphadenopathy and oligoclonaI T-cells in 5 cases. J Allergy Clin Immunol2004; 113(4):734-41. (Pubitemid 38530431)
21. Ehl S, Schwarz K. Enders A et al. A variant of SCID with specific immune responses and predominance of gamma delta T-cells, J Clin Invest 2005; 115(11):3140-8. (Pubitemid 41567578)
22. de Villartay JP. Lim A. AI-Mousa H et al. A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection.J Clin Invest 2005; 115(11):3291-9. (Pubitemid 41567594)
23. Schandene L, Ferster A. Mascart-Lemone F et al. T-helper type 2-like cells and therapeutic effects of interferon-gamma in combined immunodeficiency with hypereosinophilia (Omenns syndrome). Eur J Immunol 1993; 23(1) :56-60. (Pubitemid 23031895)
24. Cavadini P, Vermi W; Facchetti F et al. AIRE deficiency in thymus of2 patients with Omenn syndrome. J Clin Invest 2005; 115(3):728-32. (Pubitemid 40322248)
25. Anderson MS, Venanzi ES. Klein L et al. Projection of an immunologicaI self shadow within the thymus by the aire protein. Science 2002; 298(5597):1395-401. (Pubitemid 35346134)
26. Marrella V, Poliani PL. Casati A et al. A hypomorphic R229Q Rag2 mouse mutant recapitulates human Omenn syndrome. J Clin Invest 2007; 117(5) :1260-9. (Pubitemid 46718414)
27. Matangkasombut P, Pichavant M. Saez DE et al. Lack of iNKT cells in patients with combined immune deficiency due to hypomorphic RAG mutat ions. Blood 2007 [epub ahead of printJ
28. Khiong K, Murakami M. Kitabayashi C et al. Homeostatically proliferating CD4 T-cells are involved in the pathogenesis of an Omenn syndrome murine model.J Clin Invest 2007; 117(5):1270-81. (Pubitemid 46718415)
29. Milner JD, Ward JM. Keane-Myers A et al. Lymphopenic mice reconstituted with limited repertoire T-cells develop severe. multiorgan, Th2-associated inflammatory disease. Proc Natl Acad Sci USA 2007; 104(2) :576-81. (Pubitemid 46123067)
30. Milner J, WardJ, Keane-Myers A et al. Repertoire-dependent immunopathology. J Autoimmun 2007; 29 (4):257-61. (Pubitemid 47633141)
31. Bosma GC, Custer RP,Bosma MJ. A severecombined immunodeficiency mutation in the mouse. Nature 1983; 301(5900):527-30.
32. Fulop GM, Phillips RA. The scid mutation in mice causes a general defect in DNA repair. Nature 1990; 347479-482.
33. Biedermann KA, Sum JR, Giaccia AJ et al. Scid mutation in mice confers hypersensitivity to ionizing radiation and a deficiency in DNA double-strand break repair. Proc Natl Acad Sci USA 1991; 88:1394-1397. (Pubitemid 21916230)
34. Hendrickson EA, Qin XQ, Bump EA et al. A link between double-strand break related repair and V(D)J recombination: the scid mutation. Proc Natl Acad Sci USA 1991; 88:4061-4065. (Pubitemid 21914478)
35. Lieber MR, Hesse JE, Lewis S et al. The defect in murine severe combined immune deficiency: joining of signal sequences but not coding segments in V(D)J recombination. Cell 1988; 55(1):7-16.
36. Roth DB, MenetskiJP, Nakajima PB et al. V(D)J recombination: broken DNA moleculeswith covalently scaled (hairpin) coding ends in scid mouse thymocytes. Cell 1992; 70(6):983-91.
37. Taccioli GE, Rathbun G, Oltz E et al. Impairment of V(D)J recombination in double-strand break repair mutants. Science 1993; 260(5105):207-10. (Pubitemid 23140884)
38. Pergola F, Zdzienicka MZ, Lieber MR. V(D)J recombination in mammalian cell mutants defective in DNA double-strand break repair. Mol Cell Bioi 1993; 13(6):3464-71. (Pubitemid 23157283)
39. Weterings E, van Gent DC. The mechanism of nonhomologous end-joinlng: a synopsis of synapsis. DNA Repair (ArnstJ 2004; 3(11):1425-35. (Pubitemid 39221740)
40. Cavazzana-Calvo M, Le Deist F, de Saint Basile G et al. Increased radiosensitivity of granulocyte macrophage colony-forming units and skin fibroblasts in human autosomal recessiveSevere Combined Immunodeficiencj. J Clin Invest 1993; 91:1214-1218. (Pubitemid 23095301)
41. Moshous D, Li L, de Chasseval Ret al. A new gene involved in DNA double-strand break repair and V(D)J recombination is located on human chromosome lOp. Hum Mol Genet 2000; 9(4):583-588. (Pubitemid 30154016)
42. Nicolas N, Moshous D, Papadopoulo D et al. A human scmcondition with increased sensitivity to ionizing radiations and impaired V(D)J rearrangements defines a new DNA Recombination/Repair deficiencyJ Exp Med 1998; 188:627-634. (Pubitemid 28387926)
43. Nicolas N, Finnic NJ, Cavazzana-Calvo M et al. Lack of detectable defect in DNA double-strand break repair and DNA-dependant protein kinase activity in radiosesitive human severe combined immunodeficiency fibroblasts. EurJ Immuno11996; 26:1118-1122. (Pubitemid 26158511)
44. Li L, Drayna D, Hu D et al. The gene for severe combined immunodeficiency disease in Athabascanspeaking Native Americans is located on chromosome lOp. AmJ Hum Genet 1998; 62(1):136-44. (Pubitemid 28093843)
45. Moshous D, Callebaut I, de Chasseval Ret al. ARTEMIS, a Novel DNA Double-Strand Break Repair/V(D)J Recombination Protein, is Mutated in Human Severe Combined Immune Deficiency. Cell 2001; 105:177-186. (Pubitemid 32429508)
46. Rooney S, Sekiguchi J, Zhu C et al. Leaky Scid phenotype associated with defective V(D)J coding end processing in Artemis-deficient mice. Mol Cell 2002; 10(6):1379-90. (Pubitemid 36050879)
47. Li L, Salido E, Zhou Y et al, Targeted disruption of the Artemis murine counterpart results in scmand defective V(D)J recombination that is part ially corrected with bone marrow transplantation.J Immunol 2005; 174(4) :2420-8. (Pubitemid 40223992)
48. Gennery AR, Hodges E, Williams AP et al. Omenns syndrome occurring in patients without mutations in recombination activating genes. Clin Immunol 2005; 116(3) :246-56. (Pubitemid 41112728)
49. EvansPM, Woodbine L, Riballo E et al. Radiation-induced delayed cell death in a hypomorphic Artemis cell line. Hum Mol Genet 2006; 15(8):1303-11.
50. Aravind L, An evolutionary classification of the merallo-bera-lactamase fold proteins. In Silico Bioi 1999; 1(2):69-91.
51. Ma Y, Pannicke U, Schwarz K et al. Hairp in opening and overhang processing by an Artemis/DNA, dependent protein kinase complex in nonhomologous end joining and V(D)J recombination. Cell 2002; 108(6) :781,94. (Pubitemid 34327530)
52. Lenain C, Bauwens S, Amiard S et al. The Apollo 5′ exonuclease functions together with TRF2 [0 protect telomeres from DNA repair. Curr Bioi 2006; 16(13) :1303-10. (Pubitemid 43996886)
53. van Overbeck M, de Lange T. Apollo, an Artemis-related nuclease, interacts with TRF2 and protects human telomeres in S phase. Curr Bioi 2006; 16(13):1295-302 .
54. Inagaki K, Ma C, Storm TA et al. A Role ofDNA-PKcs and Artemis in Opening Viral DNA Hairpin Termini in Various Tissues in Mice.J Virol 2007; 81(20) :11304-21 (Pubitemid 47536102)
55. Callebaur I, Moshous D, Momon JP et al. Metallo-Bdactamase fold within nucleic acids processing enzymes: the fl-CASP family. Nucl Acid Res 2002; 30:3592-3601. (Pubitemid 34919215)
56. Poinsignon C, Moshous D, Callebaut I et al. The Metallo-fl-Lactamase/fl- CASP Domain of Artemis Constitutes the Catalytic Core Required for V(D)J Recombination.J Exp Med 2004; 199:315-321. (Pubitemid 38252044)
57. Pannicke U, Ma Y, Hopfner KP et al. Functional and biochemical dissection of the srructure-specific nuclease ARTEMIS. EMBOJ 2004; 23(9):1987-97. (Pubitemid 38902077)
58. Niewolik D, Pannicke U. Lu H et al. DNA-PKcs dependence of Artemis endonucleolyric activity. differences between hairpins and 5′ or 3′ overhangs.J Bioi Chern 2006; 281(45) :33900-9.
59. Ishikawa H, Nakagawa N. Kuramitsu S et al.Crystalstructure of TTHA0252 from Thermus thermo philus HB8, a RNA degradation protein of the rnetallo-bera-Iactamase superfamily.J Biochern (Tokyo) 2006; 140(4):535-42. (Pubitemid 44870918)
60. Mandel CR, Kaneko S. Zhang H et al. Polyadenylation factor CPSF-73 is the pre-mRNA 3′-endprocessing endonuclease. Nature 2006; 444(7121) :953-6. (Pubitemid 46025011)
61. Poinsignon C, de Chasseval R, Soubeyrand S et al. Phosphorylation of Artemis following irradiationinduced DNA damage. EurJ Immunol 2004; 34(11) :3146-55. (Pubitemid 39549393)
62. Riballo E, Kuhne M. Rief N et al. A pathway of double-strand break rejoining dependent upon ATM, Artemis and proteins locating to gamma-H2AX foci. Mol Cell 2004; 16(5):715-24. (Pubitemid 39586530)
63. Zhang X, SucciJ, Feng Z et al. Artemis is a phosphorylation target of ATM and ATR and is involved in the GUM DNA damage checkpoint response. Mol Cell Bioi 2004; 24(20):9207-20. (Pubitemid 39313922)
64. Chen L, Morio T. Minegishi Y et al. Ataxia-telangiectas ia-mutated dependent phosphorylation of Artemis in response to DNA damage. Cancer Sci 2005; 96(2) :134-41. (Pubitemid 40425390)
65. Ma Y, Pannicke U. Lu H et al. The DNA-dependent protein kinase catalytic subunit phosphorylation sites in human Artemis.J Bioi Chern 2005; 280(40):33839-46. (Pubitemid 41443103)
66. WangJ. Pluth JM. Cooper PK et al. Artemis deficiencyconfers a DNA double-strand break repair defect and Artemis phosphorylation status is altered by DNA damage and cell cycle progression. DNA Repair (Arnst) 2005; 4(5) :556-70. (Pubitemid 40462044)
67. Soubeyrand S, Pope L, De ChassevalRet al. Artemis phosphorylated by DNA-dependent protein kinase associates preferentially with discrete regions of chromatin. J Mol Bioi 2006; 358(5): 1200-11.
68. Goodarzi AA, Yu Y, Riballo E et al. DNA-PK autophosphorylation facilitates Artemis endonuclease activity. EMBO J 2006; 25(16):3880-9. (Pubitemid 44300273)
69. Drouer J , Frit P. Delteil C et al. Interplay between Ku, Artemis and the DNA-dependent protein kinase catalytic subunit at DNA ends.J Bioi Chern 2006: 281(38) :27784-93. (Pubitemid 44418983)
70. Rogakou EP, Pilch DR. Orr AH et al. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139.J Bioi Chern 1998; 273(10) :5858-68. (Pubitemid 28124064)
71. Darroudi F, Wiegant W; Meijers M et al. Role of Artemis in DSB repair and guarding chromosomal stability following exposure to ionizing radiation at different stages of cell cycle. Murat Res 2007; 615(1-2) :111-24. (Pubitemid 46054084)
72. Povirk LF, Zhou T. Zhou R et al. Processing of 3′-phosphoglycolace- rerminared DNA double strand breaks by Artemis nuclease.J Bioi Chern 2007; 282(6) :3547-58. (Pubitemid 47084423)
73. Sancar A, Lindsey-Boltz LA. Unsal-KacmazK et al. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 2004; 7339-85.
74. Geng L, Zhang X. Zheng S et al. Artemis links ATM to GUM checkpoint recovery via regulation of Cdkl-cyclin B.Mol Cell Bioi 2007; 27(7):2625-35 . (Pubitemid 46581353)
75. Krernpler A, Deckbar D. Jeggo PA et al. An imperfect G2M checkpoint contributes to chromosome instability following irradiation of Sand G2 phase cells. Cell Cycle 2007: 6(14):1682-6. (Pubitemid 47327917)
76. Deckbar D, BirrauxJ, Krempler A et al, Chromosome breakage alter G2 checkpoint release.J Cell Bioi 2007; 176(6):749-55. (Pubitemid 46425534)
77. O'Driscoll M, Cerosaletri KM. Girard PM et al, DNA ligase IV mutations ident ified in patients exhibiting developmental delay and immunodeficiency. Mol Cell 2001; 8(6):1l75-85.
78. Ben-Omran TI. Cerosalerri K. Concannon P et al, A patient with mutations in DNA LigaseIV: clinical features and overlap with Nijmegen breakage syndrome. Arn J Med Genet A 2005: 137(3):283-7. (Pubitemid 41262661)
79. Buck D, Moshous D. de Chasseval R et al, Severe combined immunodeficiency and microcephaly in siblings with hypomorphic mutations in DNA ligase IV. EurJ Immunol2006; 36(1) :224-35. (Pubitemid 43116409)
80. Enders A, Fisch P. Schwarz K et al. A severe form of human combined immunode6ciency due to mutations in DNA ligase IV.J Immunol 2006; 176(8) :5060-8.
81. van der Burg M. van VeelenLR. Verkaik NS et al, A new type of radiosensitive T-B-NK+ severecombined immunodeficiency caused by a LIG4 mutation. J Clin Invest 2006: 116(1):137-45. (Pubitemid 43121798)
82. Buck D, Malivert L. de Chasseval R et al. Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeóciency with microcephaly. Cell 2006; 124(2):287-99. (Pubitemid 43121978)
83. Revy P, Buck D. le Deist F et al. The repair of DNA damages/modi6cations during the maturation of the immune system: lessons from human primary immunodeficiency disorders and animal models. Adv Immunol 2005: 87237-95.
84. Ahnesorg P, Smith P,Jackson SP. XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining. Cell 2006; 124(2):301-13. (Pubitemid 43121979)
85. Zha S, Alt FW; Cheng HL et al. Defective DNA repair and increased genomic instability in Cernunnos-XLF-deficient murine ES cells. Proc Natl Acad Sci USA 2007; 104(11):4518-23. (Pubitemid 47186257)
86. Dai Y,Kysela B, Hanakahi LA et al. Nonhomologous end joining and V(D)J recombination require an additional factor. Proc Natl Acad Sci USA 2003 ; 100(5) :2462-7.
87. Hentges P, Ahnesorg P, Pitcher RS et al. Evolutionary and functional conservation of the DNA nonhomologous end-joining protein, XLF/Cernunnos.J BioI Chern 2006; 281(49):37517-26. (Pubitemid 46042055)
88. Sibanda BL, Critchlow SE, BegunJ et al. Crystal structure of an Xrcc4-DNA ligase IV complex. Nat Struct Bioi 2001; 8(12) :1015-9. (Pubitemid 33101619)
89. Junop MS, Modesti M, Guarne A et al,Crystal structure of the Xrcc4 DNA repair protein and implications for end joining. EMBOJ 2000; 19(22) :5962-70.
90. Callebaut I, Malivert L, Fischer A et al. Cernunnos interacts with the XRCC4 × DNA-ligase IV complex and is homologous to the yeast nonhomologous end-joining factor Nej1.J BioI Chern 2006; 281(20):13857-60. (Pubitemid 43848307)
91. Lu H, Pannickc: U.Schwarz K et al. Length-dependent binding of human XLF to DNA and stimulation of XRCC4.DNA ligase IV activity.J Bioi Chern 2007; 282(15):11155-62. (Pubitemid 47100736)
92. Deshpande RA, Wilson TE. Modes of interaction among yeast Nejl, Lifl and Dnl4 proteins and comparison to human XLF, XRCC4 and Lig4. DNA Repair (Arnst) 2007; 6(10):1507-16. (Pubitemid 47386045)
93. Frank-Vaillant M. Marcand S. NHEJ regulation by mating type is exercised through a novel protein. Lifzp, essential to the ligase IV pathway. Genes Dev 2001 ; 15(22) :3005-12.
94. Kegel A, SjostrandJO. Astrom SU Nejlp, a cell type-specific regulator of nonhomologous end joining in yeast. CUrt BioI 2001 ; 11(20) :1611-7. (Pubitemid 32978528)
95. Valencia M, Benrele M. VazeMB et al. NEJ1 controls nonhomologous end joining in Saccharomyces cerevisiae. Nature 2001; 414(6864):666-9. (Pubitemid 33151265)
96. Cavero S, Chahwan C, Russell P. Xlfl is required for DNA repair by nonhomologous end joining in Schizosaccharomyces pombe. Genetics 2007; 175(2):963-7. (Pubitemid 46798291)
97. Wu PY, Frit P. Malivert L et al, Interplay between Cernunnos/Xl.F and nonhomologous end-joining proteins at DNA ends in the cellJ BioI Chern 2007; 282(44):31937-43. (Pubitemid 350106409)
98. Ahnesorg p, Jackson SP. The nonhomologous end-joining protein Nejlp is a target of the DNA damage checkpoint. DNA Repair (Amsr) 2007 ; 6(2) :190-201. (Pubitemid 46074493)
99. Grawunder U, Zimmer D. Leiber MR. DNA ligase IV binds to XRCC4 via a motif located between rather than within its BRCT domains. Curt BioI 1998; 8(15) :873-6. (Pubitemid 28356047)
100. Teo SH,Jackson SP. Liflp targets the DNA ligase Lig4p to sites of DNA double-strand breaks. Curr BioI 2000 ; 10(3) :165-8. (Pubitemid 30115750)
101. Grawunder U, Wilm M. Wu × et al. Activity ofDNA ligase IV stimulated by complex formation with XRCC4 protein in mammalian cells. Nature 1997; 388(6641):492-5. (Pubitemid 27328929)
102. Tsai CJ, Kim SA, Chu G. Cernunnos/XLF promotes the ligation of mismatched and noncohesive DNA ends. Proc Natl Acad Sci USA 2007 ; 104(19) :7851-6. (Pubitemid 47185840)
103. Gu J, Lu H. Tsai AG et al. Single-stranded DNA ligation and Xl.F-sdmulared incompatible DNA end ligation by the XRCC4-DNA ligase IV complex : influence of terminal DNA sequence. Nucleic Acids Res 2007 ; 35(17):5755-62. (Pubitemid 47506292)
104. Gao Y,Sun Y,Frank KM et al.A critical role for DNA end-joining proteins in both Iymphogenesis and neurogenes is. Cell 1998; 95(7) :891-902. (Pubitemid 29019042)
105. Frank KM, Sekiguchi JM. Seidl KJ et al. Late embryonic lethality and impaired V(D)J recombination in mice lacking DNA ligase IV. Nature 1998; 396(6707):173-7. (Pubitemid 28523619)
106. Franco S, Ale FW; Manis JP. Pathways that suppress programmed DNA breaks from progressing to chromosomal breaks and translocations. DNA Repair (Arnst) 2006; 5(9-10) :1030-41. (Pubitemid 44308467)
107. Moshous D, Pannerier C. Chasseval Rd R et al. Partial T- and Bvlymphocyte immunodeficiency and predisposition to lymphoma in patients with hypomorphic mutations in Artemis. J Clin Invest 2003 ; 111(3):381-7. (Pubitemid 36182215)